|
Sanchez-Camara S, Asensio-Lopez MC, Royo-Villanova M, Soler F, Jara-Rubio R, Garrido-Penalver JF, Pinar E, Hernandez-Vicente A, Hurtado JA, Lax A, Pascual-Figal DA. Critical warm ischemia time point for cardiac donation after circulatory death. Am J Transplant. 2022 May;22(5):1321-1328. doi: 10.1111/ajt.16987. Epub 2022 Feb 21. PubMed PMID: 35114047; PubMed Central PMCID: PMC9303247.
AÑO: 2022; IF: 8.8
|
|
Delgado-Jimenez JF, Segovia-Cubero J, Almenar-Bonet L, de Juan-Baguda J, Lara-Padron A, Garcia-Pinilla JM, Bonilla-Palomas JL, Lopez-Fernandez S, Mirabet-Perez S, Gomez-Otero I, Castro-Fernandez A, Diaz-Molina B, Goirigolzarri-Artaza J, Rincon-Diaz LM, Pascual-Figal DA, Anguita-Sanchez M, Muniz J, Crespo-Leiro MG. Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics. J Clin Med. 2022 Feb 22;11(5):1170. doi: 10.3390/jcm11051170. PubMed PMID: 35268260; PubMed Central PMCID: PMC8910891.
AÑO: 2022; IF: 4.964
|
|
Rodriguez-Leor O, Cid-Alvarez AB, Perez de Prado A, Rossello X, Ojeda S, Serrador A, Lopez-Palop R, Martin-Moreiras J, Rumoroso JR, Cequier A, Ibanez B, Cruz-Gonzalez I, Romaguera R, Raposeiras S, Moreno R; investigators of the Infarction Code Working Group of the Interventional Cardiology Association of the Spanish Society of Cardiology. Analysis of the management of ST-segment elevation myocardial infarction in Spain. Results from the ACI-SEC Infarction Code Registry. Rev Esp Cardiol (Engl Ed). 2022 Aug;75(8):669-680. doi: 10.1016/j.rec.2021.12.005. Epub 2022 Jan 20. English, Spanish. PubMed PMID: 35067471.
AÑO: 2022; IF: 5.9
|
|
Verma S, Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Peil B, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Reduced trial committees and investigators. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Lancet Diabetes Endocrinol. 2022 Jan;10(1):35-45. doi: 10.1016/S2213-8587(21)00292-8. Epub 2021 Nov 30. PubMed PMID: 34861154.
AÑO: 2022; IF: 44.5
|
|
Chalkias A, Skoulakis A, Papagiannakis N, Laou E, Tourlakopoulos K, Pagonis A, Michou A, Ntalarizou N, Mermiri M, Ragias D, Bernal-Morell E, Cebreiros Lopez I, Garcia de Guadiana-Romualdo L, Eugen-Olsen J, Gourgoulianis K, Pantazopoulos I; SPARCOL Investigators. Circulating suPAR associates with severity and in-hospital progression of COVID-19. Eur J Clin Invest. 2022 Jul;52(7):e13794. doi: 10.1111/eci.13794. Epub 2022 May 4. PubMed PMID: 35435245; PubMed Central PMCID: PMC9111634.
AÑO: 2022; IF: 5.5
|
35114047